Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura

Transfusion Science

Volumn 19, Issue 3, 1998, Pages 279-288

  Blanchette, Victor ^a,b   Carcao, Manuel ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PREDNISONE; RHESUS D ANTIBODY;

CORTICOSTEROID THERAPY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; REVIEW; SPLENECTOMY; THROMBOCYTE COUNT;

EID: 0347651357     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(98)00042-3     Document Type: Article

References (23)

1. Schulman I, Currimbhoy Z: Platelet stimulating properties of human plasma with observations of the role of the spleen and the pathogenesis and treatment of ITP. Am J Diseases of Children 1960; 100:747-748.
2. Reiquam CW, Prosper JC: Fresh plasma transfusions in the treatment of acute thrombocytopenic purpura. J Pediatrics 1966; 68:880-884.
3. Masson PL: The therapeutic use of human immunoglobulins selected on the basis of their antibody activity against circulating antigens. In Peeters H, Wright PH, (eds): Plasma Protein Pathology. London, Pergamon Press, 1979, 35-44.
4. Imbach P, Barandun S, d'Apuzzo V, et al: High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 11981; 1228-1230.
5. Blanchette VS, Semple JS, Freedman JJL: Intravenous immunoglobulin and Rh immunoglobulin as immunomodulators of autoimmunity to blood elements. In Silberstein LE, (ed.): Autoimmune Disorders of Blood. American Association of Blood Banks, Bethesda, Maryland. 1996, 35-77.
6. Woerner SJ, Abildgaard CF, French BN: Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981; 67:453-460.
7. Blanchette VS, Luke B, Andrew M, et al.: A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993; 123:989-995.
8. Blanchette VS, Imbach P, Andrew M, et al.: Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344:703-707.
9. Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatrica, Suppl 1998; 424:71-74.
10. George JN, Woolf SH, Raskob GE, et al.: Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
11. Bussel JB, Schulman I, Hilgartner MW, Barandun S. Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. J Pediatr 1983; 103:651-654.
12. Ballin A, Andrew M, Ling E, Perlman M, Blanchette V: High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr 1988; 112:789-792.
13. Calderwood S, Blanchette V, Doyle J, Freedman J, Stroncek D, Zipursky A. Idiopathic thrombocytopenia and neutropenia in childhood. Am J Pediatr Hematol/Oncology 1994; 16:95-101.
14. Bussel JB, Pham LC. Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: Review of the literature. Vox Sang 1987; 52:206-211.
15. Bussel JB, Pham LC, Aledort L, Nachman R. Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 1988; 72:121-127.
16. Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling P. Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. Blood 1993; 82:1415-1421.
17. Shulman NR, Weinrach RS, Libre EP, Andrews HL. The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am Phys 1965; 78:374-389.
18. Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia: Competititve inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet ii 1983; 193-195.
19. Scaradavou A, Woo B, Woloski BMR, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 1997; 89:2689-2700.
20. Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect. Blood 1991; 77:1884-1893.
21. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991; 77:31-33.
22. Andrew M, Blanchette VS, Adams M, Ali K, Barnard D, Chan KW, DeVeber LB, Esseltine D, Israels S, Korbrinsky N, Luke B, Milner RA, Woloski BMR, Vegh P. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purura with anti-D. J Pediatr 1992; 120:522-527.
23. Kurlander RJ, Hall J. Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice. J Clin Invest 1986; 77:2010-2018.